Healthcare revenue as reported declined 2% in the quarter to $732.8 million compared with $744.1 million in the second quarter of fiscal 2022. Fiscal 2023 second quarter revenue for Applied Sterilization Technologies increased 13% as reported to $232.4 million compared with $204.9 million in the same period last year. Life Sciences second quarter revenue as reported declined 5% to $125.8 million compared with $132.3 million in the second quarter of fiscal 2022. Dental second quarter revenue as reported declined 5% to $109.6 million compared with $115.6 in the second quarter of fiscal 2022.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on STE: